169 results on '"Moore, Ian N."'
Search Results
2. Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
3. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
4. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
5. CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
6. Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
7. Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis
8. A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion.
9. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
10. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure
11. Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor
12. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
13. Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses
14. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques
15. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
16. Human norovirus targets enteroendocrine epithelial cells in the small intestine
17. Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection
18. A primate model of severe malarial anaemia: a comparative pathogenesis study
19. TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome
20. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
21. A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
22. Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines
23. An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques
24. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
25. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
26. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
27. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
28. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
29. Virus infection of the CNS disrupts the immune-neural-synaptic axis via induction of pleiotropic gene regulation of host responses
30. A Long-Acting Thermoresponsive Injectable Formulation of Tin Protoporphyrin Sustains Antitubercular Efficacy in a Murine Infection Model
31. Heme Oxygenase-1 Induction by Blood-Feeding Arthropods Controls Skin Inflammation and Promotes Disease Tolerance
32. Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans
33. Alternaria alternata Accelerates Loss of Alveolar Macrophages and Promotes Lethal Influenza A Infection
34. Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis
35. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
36. Differing Virulence of Healthy Skin Commensals in Mouse Models of Infection
37. Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis
38. Limited Pulmonary Mucosal-Associated Invariant T Cell Accumulation and Activation during Mycobacterium tuberculosis Infection in Rhesus Macaques
39. A Long-Acting Thermoresponsive Injectable Formulation of Tin Protoporphyrin Sustains Antitubercular Efficacy in a Murine Infection Model.
40. Prolonging culture of primary human keratinocytes isolated from suction blisters with the Rho kinase inhibitor Y-27632
41. Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
42. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis
43. Immunity to LuloHya and Lundep, the salivary spreading factors from Lutzomyia longipalpis, protects against Leishmania major infection
44. Ticks, Ixodes scapularis, Feed Repeatedly on White-Footed Mice despite Strong Inflammatory Response: An Expanding Paradigm for Understanding Tick–Host Interactions
45. In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
46. Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model
47. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
48. In Vivo Imaging of Influenza Virus Infection in Immunized Mice
49. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure.
50. Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.